{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:55:10Z","timestamp":1789588510389,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ophtha.2014.08.015","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T18:08:51Z","timestamp":1412273331000},"page":"248-253","source":"Crossref","is-referenced-by-count":67,"title":["Prosthetic Replacement of the Ocular Surface Ecosystem as Treatment for Ocular Surface Disease in Patients with a History of Stevens\u2013Johnson Syndrome\/Toxic Epidermal Necrolysis"],"prefix":"10.1016","volume":"122","author":[{"given":"Thanos D.","family":"Papakostas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Gam","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.08.015_bib1","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.08.015_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.08.015_bib3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","article-title":"The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy","volume":"91","author":"De Rojas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"62","author":"Yip","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.ophtha.2014.08.015_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2010.06.035","article-title":"Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis","volume":"118","author":"L\u00f3pez-Garc\u00eda","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.08.015_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-014-2568-8","article-title":"Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition","volume":"252","author":"Iyer","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICU.0b013e3283622718","article-title":"Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"24","author":"Ciralsky","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2009.07.037","article-title":"Clinical benefits of the Boston Ocular Surface Prosthesis","volume":"149","author":"Stason","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0896-1549(02)00067-6","article-title":"The Boston Scleral Lens in the management of severe ocular surface disease","volume":"16","author":"Rosenthal","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ophtha.2014.08.015_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","article-title":"Boston Scleral Lens Prosthetic Device for treatment of severe dry eye in chronic graft-versus-host disease","volume":"26","author":"Jacobs","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.08.015_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9394(00)00378-0","article-title":"Gas-permeable scleral contact lens therapy in ocular surface disease","volume":"130","author":"Romero-Rangel","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(14)74558-1","article-title":"A\u00a0gas-permeable scleral contact lens for visual rehabilitation","volume":"109","author":"Schein","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bbmt.2007.05.006","article-title":"Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease","volume":"13","author":"Takahide","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ophtha.2014.08.015_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clae.2012.04.003","article-title":"PROSE treatment of corneal ectasia","volume":"35","author":"Baran","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ophtha.2014.08.015_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/ICO.0b013e318201467c","article-title":"The Cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure","volume":"30","author":"Biber","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.08.015_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2012.07.053","article-title":"Visual improvement after cultivated oral mucosal epithelial transplantation","volume":"120","author":"Sotozono","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.08.015_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2007.11.002","article-title":"The Boston keratoprosthesis in Stevens-Johnson syndrome","volume":"145","author":"Sayegh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib18","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/ICO.0b013e318215207c","article-title":"The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience","volume":"30","author":"Pujari","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.08.015_bib19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ajo.2013.06.012","article-title":"Mucosal complications of modified osteo-odonto keratoprosthesis in chronic Stevens-Johnson syndrome","volume":"156","author":"Basu","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajo.2010.11.011","article-title":"Impact of clinical factors on the long-term functional and anatomic outcomes of osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis","volume":"151","author":"De La Paz","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","article-title":"Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"148","author":"Tougeron-Brousseau","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2014.03.012","article-title":"Prosthetic Replacement of the Ocular Surface Ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome","volume":"158","author":"Heur","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2014.01.028","article-title":"Scleral lenses in the management of ocular surface disease","volume":"121","author":"Schornack","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.08.015_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ajo.2009.07.012","article-title":"Economic appraisal of the Boston Ocular Surface Prosthesis","volume":"148","author":"Shepard","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hec.864","article-title":"Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis","volume":"13","author":"Devlin","year":"2004","journal-title":"Health Econ"},{"key":"10.1016\/j.ophtha.2014.08.015_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ophtha.2014.08.015_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajo.2009.08.027","article-title":"Cost-effectiveness of the Boston keratoprosthesis","volume":"149","author":"Ament","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.08.015_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/eye.2010.197","article-title":"Cost effectiveness of the type II Boston keratoprosthesis","volume":"25","author":"Ament","year":"2011","journal-title":"Eye (Lond)"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014007532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014007532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:53:49Z","timestamp":1538157229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014007532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0161642014007532"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.08.015","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}